AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 784 businesses audited.
Medical Devices, Pharma & Biotech BS: XGEVA (Amgen) (xgeva.com)
This is a benchmark site for pharmaceutical substance, trading marketing ‘magic’ for rigorous clinical metrics. It contains almost no bullshit, functioning as a high-fidelity data bridge between the manufacturer and the patient.
Consolidate the repeated H2 headings on the ‘Learn’ page to improve technical structure. Remove the ‘Good news!’ placeholder marketing text on the ‘Why Bones Matter’ page and replace it with more specific skeletal risk data. Ensure the Schema sameAs links include direct entries to ClinicalTrials.gov registrations for the three primary studies cited.
The information density is exceptionally high for a consumer-facing site. While the H1 ‘Your bones matter’ is a generic emotional hook, the sub-pages deliver granular substance, citing specific trial populations (e.g., ‘5,723 people who had breast, prostate, and other types of solid tumors’) and measurable outcomes like the ‘18% less likely’ risk reduction and ‘21.4 months vs 15.4 months’ efficacy delta. Fluff is almost non-existent in the clinical data sections, which prioritize technical protocols over power words.
AI does not see your layout — it sees your DOM. Get a Clinical Semantic Structure Diagnosis to reveal how your page is segmented, weighted, and interpreted.
There is zero semantic drift between the primary signal and the internal substance. The homepage promise of ‘Serious Bone Problem Prevention’ is met with a deep dive into skeletal-related event (SRE) data and comparative studies against zoledronic acid (ZA). The content remains strictly aligned with the FDA-indicated uses throughout the navigation flow.
Move beyond vague agency reporting and visualize your surgical implementation plan. Order an Executive SEO Strategy and stop relying on superficial keyword tracking.
Trust theatre is absent; the site relies on hard clinical evidence rather than unverified ‘stars’ or vague testimonials. The review_count and proof_links_count are anchored by outbound links to the Full Prescribing Information and Safety Info PDFs, providing the necessary regulatory proof paths for every medical claim made.
The ratio of evidence to assertion is high, especially on the ‘Learn about XGEVA’ page. For every claim of superiority, there is a corresponding citation of clinical study duration (27 months), participant count, and percentage-based probability results (18% less likely).
To see how the system reconstructs a medical entity graph at scale, review the full Cleveland Clinic Structured Data audit. View the Cleveland Clinic Structured Data Audit for a live example of identity level decomposition and cross page entity mapping.
The site carries a standard pharmaceutical template fingerprint, particularly in its ‘Ready to Start’ call-to-action blocks and mandatory ‘Important Safety Information’ footers. While it uses generic industry phrases like ‘staying on track’ and ‘financial support,’ these are exempt from high penalties as they lead to specific, non-fluff resources like the Amgen SupportPlus Co-Pay Program.
Authority is solidly established through the manufacturer identity (AMGEN) and the inclusion of extensive Drug and MedicalIndication schema. There are no gaps where an expert’s name is used without verification; instead, the site deferentially points to the user’s oncologist and the American Dental Association (ADA) for specific oral health protocols.
There is no disconnect between claims and evidence. Performance claims such as ‘prevented serious bone problems 6 months longer than ZA’ are immediately supported by study size data (1,597 people) and specific medians (21.4 vs 15.4 months). The marketing tone is secondary to the clinical demonstration.
Medical Devices, Pharma & Biotech BS: XGEVA (Amgen) (xgeva.com)
The site perfectly matches the Pharma & Biotech industry, utilizing heavy regulation-driven content such as Prescribing Information (PI), specific active ingredients (denosumab), and clinical trial data comparisons.
AI cannot build a coherent graph if the same page resolves into multiple identities. Explore the URL & Canonical Hygiene Technical Framework to understand how identity stability prevents duplicate embeddings and semantic drift.
“The score of 14 is driven primarily by the high information density and absence of semantic drift. Minor points were only accrued for template repetition and the use of standard pharma industry cliches ('Ready to Start', 'Good News').”
Analysis Disclosure & Source Attribution
Snapshot Date: June 20, 2026
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to see how machine logic interprets digital signals.
Machine Perception Notice: This evaluation is generated by machine-read logic (MRL). The AI interprets the “Digital Ghost” of a website (code, metadata, and semantic structures), which may differ from what a human sees at the same moment. This is an automated technical diagnostic and not a statement of fact or human opinion regarding the real-world integrity or legitimacy of the business. Any missing or inaccessible elements in the snapshot are treated as machine-read signals, reflecting AI rendering limitations rather than intentional omission.
Notice to the Evaluated Business: This analysis is part of a non-adversarial audit. The results are intended as professional feedback to help improve machine-readability and authority signals. Any company can use these insights for free. When content is updated, a fresh audit can be requested at any time to reflect the current state.
To All Users: You are encouraged to visit the live site at XGEVA (Amgen) to view the most current version of their content and see directly what the company offers.